loadpatents
name:-0.024538993835449
name:-0.016268014907837
name:-0.0040848255157471
HIRAI; Hiroshi Patent Filings

HIRAI; Hiroshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for HIRAI; Hiroshi.The latest application filed is for "pharmaceutical composition and therapeutic method for treating fgfr1 variant-positive brain tumor".

Company Profile
3.16.21
  • HIRAI; Hiroshi - Port Klang Selangor Darul Ehsan
  • HIRAI; Hiroshi - Tokyo JP
  • Hirai; Hiroshi - Tsukuba JP
  • HIRAI; Hiroshi - Tsukuba-shi JP
  • Hirai; Hiroshi - Ibaraki JP
  • Hirai; Hiroshi - Kanagawa JP
  • Hirai; Hiroshi - Memphis TN
  • Hirai; Hiroshi - Ryugasaki JP
  • Hirai; Hiroshi - Saitama JA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method Of Producing Refined Oil And/or Fat
App 20220240532 - YONG; Chee Keat ;   et al.
2022-08-04
Pharmaceutical Composition And Therapeutic Method For Treating Fgfr1 Variant-positive Brain Tumor
App 20220241280 - HIRAI; Hiroshi ;   et al.
2022-08-04
Cancer Therapy Using 3,5-disubstituted Benzene Alkynyl Compound And Pembrolizumab
App 20220184082 - YONEKURA; Kazuhiko ;   et al.
2022-06-16
Cancer Therapy Using 3,5-disubstituted Benzene Alkynyl Compound And Immune Checkpoint Inhibitor
App 20220125793 - YONEKURA; Kazuhiko ;   et al.
2022-04-28
Therapeutic And Prophylactic Method For Tumor Treatable With Endocrine Therapy By Combined Use Of Fibroblast Growth Factor Receptor Inhibitor With Endocrine Therapy
App 20220023300 - HIRAI; Hiroshi ;   et al.
2022-01-27
Antitumor Agent And Method For Tumor Therapy
App 20210236475 - HIRAI; Hiroshi
2021-08-05
Antitumor drug for intermittent administration of FGFR inhibitor
Grant 10,894,048 - Ochiiwa , et al. January 19, 2
2021-01-19
Method For Reducing Content Of Saturated Hydrocarbon, And Refined Palm-based Oils And/or Fats
App 20200332221 - HIRAI; Hiroshi ;   et al.
2020-10-22
Antitumor Drug For Intermittent Administration Of Fgfr Inhibitor
App 20190183897 - OCHIIWA; Hiroaki ;   et al.
2019-06-20
Antitumor Drug For Intermittent Administration Of Fgfr Inhibitor
App 20160193210 - OCHIIWA; Hiroaki ;   et al.
2016-07-07
Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor
Grant 9,012,475 - Hirai , et al. April 21, 2
2015-04-21
Method For Enhancing Anti-tumor Effect Of A Microtubule-targeting Drug, And A Method For Treatment Of Tumor
App 20150065479 - HIRAI; Hiroshi ;   et al.
2015-03-05
Dihydropyrazolopyrimidinone Derivatives
App 20140303178 - Sagara; Takeshi ;   et al.
2014-10-09
Dihydropyrazolopyrimidinone derivatives
Grant 8,791,125 - Sagara , et al. July 29, 2
2014-07-29
Combination cancer therapy with an AKT inhibitor and other anticancer agents
Grant 8,481,503 - Layton , et al. July 9, 2
2013-07-09
Predictive Biomarkers Useful For Cancer Therapy Mediated By A Wee1 Inhibitor
App 20120157342 - Mizuarai; Shinji ;   et al.
2012-06-21
Combination Cancer Therapy with an AKT Inhibitor and Other Anticancer Agents
App 20110319354 - Layton; Mark E. ;   et al.
2011-12-29
Substrate, semiconductor device using the same, method for inspecting semiconductor device, and method for manufacturing semiconductor device
Grant 8,053,878 - Iwamura , et al. November 8, 2
2011-11-08
Dihydropyrazolopyrimidinone Derivatives
App 20110189130 - Sagara; Takeshi ;   et al.
2011-08-04
Dihydropyrazolopyrimidinone derivatives
Grant 7,935,708 - Sagara , et al. May 3, 2
2011-05-03
Substituted pyrazolo[3,4-d]pyrimidinone derivatives
Grant 7,834,019 - Sagara , et al. November 16, 2
2010-11-16
Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton
Grant 7,709,475 - Iwasawa , et al. May 4, 2
2010-05-04
Dihydropyrazolopyrimidinone Derivatives
App 20100063024 - Sakamoto; Toshihiro ;   et al.
2010-03-11
Novel quinoxalinone derivatives
App 20090137597 - Hirai; Hiroshi ;   et al.
2009-05-28
Quinoxalinone derivatives
Grant 7,388,010 - Hirai , et al. June 17, 2
2008-06-17
Substrate, semiconductor device using the same, method for inspecting semiconductor device, and method for manufacturing semiconductor device
App 20080105964 - Iwamura; Hiroki ;   et al.
2008-05-08
Selective Inhibitors Against Cdk4 and Cdk6 Having Aminothiazole Skeleton
App 20080081811 - Iwasawa; Yoshikazu ;   et al.
2008-04-03
Dihydropyrazolopyrimidinone derivatives
App 20070254892 - Sagara; Takeshi ;   et al.
2007-11-01
Novel quinoxalinone derivatives
App 20060019959 - Hirai; Hiroshi ;   et al.
2006-01-26
Cyclin D binding factor, and uses thereof
Grant 6,673,902 - Sherr , et al. January 6, 2
2004-01-06
Millimeter wave and far-infrared detector
Grant 6,627,914 - Komiyama , et al. September 30, 2
2003-09-30
Cyclin D binding factor, and uses thereof
App 20030028002 - Sherr, Charles J. ;   et al.
2003-02-06
InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
Grant 6,033,847 - Sherr , et al. March 7, 2
2000-03-07
Distributed data processing system having front-end and back-end computers with different operating systems
Grant 5,471,615 - Amatsu , et al. November 28, 1
1995-11-28
Negative disc brake with a clearance-takeup mechanism
Grant 4,030,577 - Ogawa , et al. June 21, 1
1977-06-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed